A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.

by Kyle Bagenstose

Some women over 70 may not need chemotherapy for high-risk breast cancer, and an early trial finds a pancreatic cancer vaccine can trigger an immune response.

by Marci A. Landsmann

Preliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.

by Sandra Gordon

A targeted therapy offers new treatment for a deadly brain cancer that mainly affects children, and more people in their 40s are getting screened for colorectal cancer.

by Marci A. Landsmann

Potential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.

by Taneia Surles

Most liver cancers can be prevented, and a common type of HPV is linked to skin cancer.

by Eric Fitzsimmons

Experts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.

by Thomas Celona

Doctors often don’t discuss sexual side effects with breast cancer survivors, and cardiac biomarkers may indicate increased risk for certain cancers.

by Thomas Celona

Less than half of people with advanced cancer undergo genomic profiling, and gastrointestinal cancer rates are rising dramatically in younger adults.

by Marci A. Landsmann

Steroids at the start of immunotherapy can negatively affect response, and colorectal cancer may lead to sexual side effects in women.

by Eric Fitzsimmons